T1	Participants 80 124	men aged ≥40 years with erectile dysfunction
T2	Participants 336 385	men aged ≥40 years with erectile dysfunction (ED)
T3	Participants 533 722	Men aged ≥40 years who were not receiving lipid lowering or anti-hypertensive medication and not at high cardiovascular risk were recruited from 10 general practices in the East of England.
T4	Participants 733 809	173 eligible men with untreated ED were randomized to double-blind treatment
T5	Participants 2020 2031	men with ED
